Press release
GEA Lyophil: saving time and money … improving yield and quality – at ACHEMA 2012
GEA Lyophil, GEA’s pharmaceutical freeze drying specialist, will be mixing established technology and cutting edge innovation on the GEA Pharma Systems stand at ACHEMA 2012. All the GEA Lyophil technology has proven its ability to improve yields, enhance quality, save money and time, and help pharmaceutical companies to unleash their product potential.Nucleation On-Demand Technology
With ControLyo®, GEA Lyophil has added nucleation on-demand technology to its pharmaceutical freeze drying range to improve yield and reduce cycle time. ControLyo®, supplied through a license agreement with Praxair, enables accurate control of the nucleation temperature of a solution, in many cases to within 1°C of the solution’s freezing point. The results are improved product uniformity, larger pore diameter, quality, yield and a reduction in cycle time by as much as 40%.
Multipurpose measurement device for pharmaceutical freeze dryers
LYOPLUS™ is also new from GEA Lyophil. It is a multipurpose measurement device for pharmaceutical freeze dryers that helps save money and time. The LYOPLUS™ mass spectrometer provides essential data from within the freeze dryer itself that allows operators to: detect very small silicone oil leaks inside the dryer; monitor the moisture content within the freeze drying chamber; identify the end point of primary and secondary drying; and detect leaks much faster and more easily.
High efficient and gentle H2O2- Gas Sterilization
The VAPOVAC™ H2O2 (Hydrogen Peroxide) sterilizer technology, provides gentle, highly efficient, cost and energy efficient, FDA proven sterilization for freeze dryers. The technology can be provided to new or existing installations without over pressure vessels to provide a short, efficient sterilization cycle.
Automatic Loading and Unloading System for Freeze Dryer
ALUS is not new but it still represents essential, leading technology for the automatic loading and unloading of pharmaceutical freeze dryers and is the central exhibit of the GEA Pharma Systems stand. This year the ALUS on show will be equipped with the new Check & Sort application to guarantee efficient and reliable monitoring and tracking of the product. There will be a live demonstration on the stand.
Experienced sales and technical staff will be available on the stand to discuss individual application. GEA Pharma Systems: ACHEMA 2012, 18-22 June, Hall 4, Stand F 44.
About GEA Pharma Systems
GEA Pharma Systems unites the technologies of Aeromatic-Fielder™, Buck™, Collette™, Courtoy™, Diessel™, and Lyophil™ to provide advanced one-stop solutions for solid and liquid dosage processing to the global pharmaceutical industry.
All editorial enquiries to:
Steve Jordan
The Words Workshop
Tel: +44 1908 695500
Email: steve@thewordsworkshop.co.uk
www.thewordsworkshop.co.uk
For further business information contact:
Hubert Kluetsch - Director Sales and Marketing
GEA Lyophil GmbH
Kalscheurener Str. 92 50354 Huerth Germany
Tel: +49 (0) 2233/6999-220 Fax: +49 (0) 2233/6999-8220
E-mail: lyophil@geagroup.com
www.geapharmasystems.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GEA Lyophil: saving time and money … improving yield and quality – at ACHEMA 2012 here
News-ID: 221749 • Views: …
More Releases from GEA Pharma Systems
Janssen Pharmaceutica teams up with GEA Pharma Systems to investigate continuous …
Janssen Pharmaceutica, part of the worldwide Janssen Pharmaceutica Group, has initiated a global project with the aim of evaluating technical performance and related business benefits of continuous processing technologies for oral solid dosage forms. In this context, ConsiGma™ continuous processing technology from GEA Pharma Systems has been assessed for tablet manufacture. During an in-depth feasibility study at GEA Pharma Systems’ lab, the team from Janssen has been able to…
GEA Pharma Systems presents European granulation, drying, tableting and fermenta …
GEA Pharma Systems will be exhibiting at CHINA-PHARM 2012 from 24 to 27 September at the China National Convention Center in Beijing. Exhibits on stand number 3017 will include examples of the company’s range of Aeromatic-Fielder™ and Collette™ granulation and drying plant; MODUL™ tablet presses from Courtoy™; and pharmaceutical fermentation systems from GEA Diessel showing state-of-the-art technology for a bioreactor vessel.
On 25 September the company will present a…
Combined pharmaceutical freeze drying service proves a success in China for GEA …
It was in November 2010 that GEA Pharma Systems acquired Beijing Sino-German Tianhe Technology in Beijing to create GEA Lyophil (Beijing) Ltd. Since then, the company has quadrupled turnover and enhanced its customer service by blending German quality and Chinese economy to provide a unique combined offering to its pharmaceutical clients.
Jinbin Tang, MD, GEA Lyophil (Beijing) Ltd. said that the market had changed in China since the introduction of new…

GEA Pharma Systems wins large order for continuous solid dose processing from ma …
GEA Pharma Systems has announced an agreement with a US pharmaceutical company to supply a complete continuous processing line for the production of solid dose drugs. The order is one of the more significant for ConsiGma™ oral solid dosage continuous processing equipment and represents the first phase of a potentially long-term commitment for this customer. Delivery is scheduled for early 2013.
The order is to deliver a continuous solid…
More Releases for Lyophil
Combined pharmaceutical freeze drying service proves a success in China for GEA …
It was in November 2010 that GEA Pharma Systems acquired Beijing Sino-German Tianhe Technology in Beijing to create GEA Lyophil (Beijing) Ltd. Since then, the company has quadrupled turnover and enhanced its customer service by blending German quality and Chinese economy to provide a unique combined offering to its pharmaceutical clients.
Jinbin Tang, MD, GEA Lyophil (Beijing) Ltd. said that the market had changed in China since the introduction of new…
Liquid and Solid dosage innovation in compression, containment and continuous pr …
GEA Pharma Systems will be demonstrating its solid dosage innovation in the areas of compression, containment and continuous processing at ACHEMA 2012 in Frankfurt from 18-22 June. Exhibits will include the new bi-layer conversion system for the high-volume Performa™ P tablet press; the range of improved Buck® valves including the MC valve and Hicoflex®; the hugely successful and versatile FlexStream™ fluid bed technology; and the revolutionary concept of ConsiGma™…
LYOPLUS® – multipurpose measurement device for pharmaceutical freeze dryers f …
One of the world’s biggest pharmaceutical companies has recently embarked on a long-term evaluation programme for the LYOPLUS® mass spectrometer from GEA Lyophil to provide essential data from within the freeze dryer itself. The company has confirmed a number of benefits of the LYOPLUS® system including: the ability to detect very small silicone oil leaks inside the dryer; the ability to monitor the moisture content within the freeze drying…
GEA Diessel reinforces its strong Japanese presence at Interphex 2011
GEA Diessel further strengthened its market position in the Japanese pharmaceutical market with its attendance at Interphex in Tokyo this July. The show, claimed to be Asia’s biggest pharmaceutical exhibition, allowed GEA Diessel the opportunity of renewing existing relationships while taking new enquiries for its advanced fermentation technology. The GEA staff on the stand reported Interphex 2011 to be equal to previous years with over 1500 companies exhibiting and…
Visitors from around the world attend GEA Lyophil open-house seminars during Int …
Visitors to the Interpack 2011 exhibition in Dϋsseldorf were given the opportunity to attend a series of special in-house seminars presented by pharmaceutical freeze dryer manufacturer GEA Lyophil. The theme of the seminars held on May 13, 14 and 17 was ‘total cost of ownership’ and focused on the reduction of direct and indirect costs in relation to the freeze drying process.
Fifty delegates from 18 countries attended the seminars at…
VAPOVAC™ : new FDA compliant H2O2 sterilisation system for pharmaceutical Lyop …
VAPOVAC™ the latest technology for H2O2 gas sterilisation of pharmaceutical freeze dryers from GEA Lyophil, has recently received a Letter of Non-Objection from the US Food and Drugs Administration (FDA).
The FDA Letter of Non-Objection has now cleared the way for GEA Lyophil to market the VAPOVAC™ system worldwide. The system is ideally suited to pharmaceutical applications that require sterile conditions without the stresses and high power usage associated with…